PML control of cytokine signaling

Ishov, 1999, PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1, J Cell Biol, 147, 221, 10.1083/jcb.147.2.221 Wang, 1998, Role of PML in cell growth and the retinoic acid pathway, Science, 279, 1547, 10.1126/science.279.5356.1547 Wang, 1998, PML is essential for multiple apoptotic pathways, Nat Genet, 20, 266, 10.1038/3030 Lin, 2004, Cytoplasmic PML function in TGF-beta signalling, Nature, 431, 205, 10.1038/nature02783 de The, 1990, The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus, Nature, 347, 558, 10.1038/347558a0 Reymond, 2001, The tripartite motif family identifies cell compartments, EMBO J, 20, 2140, 10.1093/emboj/20.9.2140 Nisole, 2005, TRIM family proteins: retroviral restriction and antiviral defence, Nat Rev Microbiol, 3, 799, 10.1038/nrmicro1248 Jensen, 2001, PML protein isoforms and the RBCC/TRIM motif, Oncogene, 20, 7223, 10.1038/sj.onc.1204765 Nisole, 2013, Differential roles of PML isoforms, Front Oncol, 3, 125, 10.3389/fonc.2013.00125 Cheng, 2012, Post-translational modifications of PML: consequences and implications, Front Oncol, 2, 210 Schmitz, 2012, Regulation of the tumor suppressor PML by sequential post-translational modifications, Front Oncol, 2, 204, 10.3389/fonc.2012.00204 Lallemand-Breitenbach, 2001, Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation, J Exp Med, 193, 1361, 10.1084/jem.193.12.1361 Pampin, 2006, Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense, J Virol, 80, 8582, 10.1128/JVI.00031-06 El Mchichi, 2010, SUMOylation promotes PML degradation during encephalomyocarditis virus infection, J Virol, 84, 11634, 10.1128/JVI.01321-10 Shen, 2006, The mechanisms of PML-nuclear body formation, Mol Cell, 24, 331, 10.1016/j.molcel.2006.09.013 Kamitani, 1998, Identification of three major sentrinization sites in PML, J Biol Chem, 273, 26675, 10.1074/jbc.273.41.26675 Galisson, 2011, A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells, Mol Cell Proteomic, 10, M110004796, 10.1074/mcp.M110.004796 Rabellino, 2012, The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA, Cancer Res, 72, 2275, 10.1158/0008-5472.CAN-11-3159 Zhong, 2000, Role of SUMO-1-modified PML in nuclear body formation, Blood, 95, 2748, 10.1182/blood.V95.9.2748.009k31a_2748_2752 Chelbi-Alix, 1995, Induction of the PML protein by interferons in normal and APL cells, Leukemia, 9, 2027 Goodbourn, 2000, Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures, J Gen Virol, 81, 2341, 10.1099/0022-1317-81-10-2341 Chelbi-Alix, 2007, Interferon, a growing cytokine family: 50 years of interferon research, Biochimie, 89, 713, 10.1016/j.biochi.2007.05.001 Sadler, 2008, Interferon-inducible antiviral effectors, Nat Rev Immunol, 8, 559, 10.1038/nri2314 Stadler, 1995, Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element, Oncogene, 11, 2565 Kim, 2007, Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells, Cancer Res, 67, 11133, 10.1158/0008-5472.CAN-07-1342 Dror, 2007, Interferon regulatory factor-8 is indispensable for the expression of promyelocytic leukemia and the formation of nuclear bodies in myeloid cells, J Biol Chem, 282, 5633, 10.1074/jbc.M607825200 Hubackova, 2012, Interleukin 6 signaling regulates promyelocytic leukemia protein gene expression in human normal and cancer cells, J Biol Chem, 287, 26702, 10.1074/jbc.M111.316869 Gao, 2008, Histone deacetylase 7 promotes PML sumoylation and is essential for PML nuclear body formation, Mol Cell Biol, 28, 5658, 10.1128/MCB.00874-08 Cheng, 2012, Promyelocytic leukemia protein (PML) regulates endothelial cell network formation and migration in response to tumor necrosis factor alpha (TNFalpha) and interferon alpha (IFNalpha), J Biol Chem, 287, 23356, 10.1074/jbc.M112.340505 Heuser, 1998, Induction of the pro-myelocytic leukaemia gene by type I and type II interferons, Mediat Inflamm, 7, 319, 10.1080/09629359890839 Bernardi, 2008, Regulation of apoptosis by PML and the PML-NBs, Oncogene, 27, 6299, 10.1038/onc.2008.305 Crowder, 2005, PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL induction, Blood, 105, 1280, 10.1182/blood-2004-04-1614 Wu, 2003, Promyelocytic leukemia protein sensitizes tumor necrosis factor alpha-induced apoptosis by inhibiting the NF-kappaB survival pathway, J Biol Chem, 278, 12294, 10.1074/jbc.M211849200 Lunardi, 2011, A role for PML in innate immunity, Gene Cancer, 2, 10, 10.1177/1947601911402682 Ohgiya, 2012, Association of promyelocytic leukemia protein with expression of IL-6 and resistance to treatment in multiple myeloma, Acta Haematol, 128, 213, 10.1159/000339486 Lo, 2013, Selective inhibition of the NLRP3 inflammasome by targeting to promyelocytic leukemia protein in mouse and human, Blood, 121, 3185, 10.1182/blood-2012-05-432104 Haneklaus, 2013, Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments, Curr Opin Immunol, 25, 40, 10.1016/j.coi.2012.12.004 Latz, 2013, Activation and regulation of the inflammasomes, Nat Rev Immunol, 13, 397, 10.1038/nri3452 Giorgi, 2010, PML regulates apoptosis at endoplasmic reticulum by modulating calcium release, Science, 330, 1247, 10.1126/science.1189157 Dowling, 2014, Promyelocytic Leukemia Protein Interacts with the Apoptosis-associated Speck-like Protein to Limit Inflammasome Activation, J Biol Chem, 289, 6429, 10.1074/jbc.M113.539692 Bonilla, 2002, Effects of promyelocytic leukemia protein on virus-host balance, J Virol, 76, 3810, 10.1128/JVI.76.8.3810-3818.2002 Chelbi-Alix, 1998, Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein, J Virol, 72, 1043, 10.1128/JVI.72.2.1043-1051.1998 Djavani, 2001, Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus, J Virol, 75, 6204, 10.1128/JVI.75.13.6204-6208.2001 El Asmi, 2014, Implication of PMLIV in both intrinsic and innate immunity, PLoS Pathog, 10, e1003975, 10.1371/journal.ppat.1003975 Blondel, 2010, Resistance to rabies virus infection conferred by the PMLIV isoform, J Virol, 84, 10719, 10.1128/JVI.01286-10 Blondel, 2002, Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies, Oncogene, 21, 7957, 10.1038/sj.onc.1205931 Chee, 2003, Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects, J Virol, 77, 7101, 10.1128/JVI.77.12.7101-7105.2003 Regad, 2001, PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator, EMBO J, 20, 3495, 10.1093/emboj/20.13.3495 Maroui, 2011, Promyelocytic leukemia isoform IV confers resistance to encephalomyocarditis virus via the sequestration of 3D polymerase in nuclear bodies, J Virol, 85, 13164, 10.1128/JVI.05808-11 Tavalai, 2006, Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections, J Virol, 80, 8006, 10.1128/JVI.00743-06 Kyratsous, 2009, Components of nuclear domain 10 bodies regulate varicella-zoster virus replication, J Virol, 83, 4262, 10.1128/JVI.00021-09 Everett, 2007, PML and PML nuclear bodies: implications in antiviral defence, Biochimie, 89, 819, 10.1016/j.biochi.2007.01.004 Geoffroy, 2011, Role of promyelocytic leukemia protein in host antiviral defense, J Interferon Cytokine Res, 31, 145, 10.1089/jir.2010.0111 El Bougrini, 2011, PML positively regulates interferon gamma signaling, Biochimie, 93, 389, 10.1016/j.biochi.2010.11.005 Choi, 2006, The promyelocytic leukemia protein functions as a negative regulator of IFN-gamma signaling, Proc Natl Acad Sci U S A, 103, 18715, 10.1073/pnas.0604800103 Ulbricht, 2012, PML promotes MHC class II gene expression by stabilizing the class II transactivator, J Cell Biol, 199, 49, 10.1083/jcb.201112015 Herzer, 2009, IFN-alpha-induced apoptosis in hepatocellular carcinoma involves promyelocytic leukemia protein and TRAIL independently of p53, Cancer Res, 69, 855, 10.1158/0008-5472.CAN-08-2831 Koken, 1997, Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies, Proc Natl Acad Sci U S A, 94, 10255, 10.1073/pnas.94.19.10255 Xu, 2009, Promyelocytic leukemia zinc finger protein regulates interferon-mediated innate immunity, Immunity, 30, 802, 10.1016/j.immuni.2009.04.013 Ozato, 2009, PLZF outreach: a finger in interferon's pie, Immunity, 30, 757, 10.1016/j.immuni.2009.06.003 Wormald, 2004, Inhibitors of cytokine signal transduction, J Biol Chem, 279, 821, 10.1074/jbc.R300030200 Hertzog, 2013, Fine tuning type I interferon responses, Cytokine Growth Factor Rev, 24, 217, 10.1016/j.cytogfr.2013.04.002 Liu, 2001, A transcriptional corepressor of Stat1 with an essential LXXLL signature motif, Proc Natl Acad Sci U S A, 98, 3203, 10.1073/pnas.051489598 Liu, 1998, Inhibition of Stat1-mediated gene activation by PIAS1, Proc Natl Acad Sci U S A., 95, 10626, 10.1073/pnas.95.18.10626 Rytinki, 2009, PIAS proteins: pleiotropic interactors associated with SUMO, Cell Mol Life Sci, 66, 3029, 10.1007/s00018-009-0061-z Saitoh, 2006, Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1, Nat Immunol, 7, 598, 10.1038/ni1347 Reichelt, 2011, Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus, PLoS Pathog, 7, e1001266, 10.1371/journal.ppat.1001266 Yang, 2009, TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response, J Immunol, 182, 3782, 10.4049/jimmunol.0803126 Lin, 2005, Deregulated TGF-beta signaling in leukemogenesis, Oncogene, 24, 5693, 10.1038/sj.onc.1208923 Carracedo, 2011, The nuclear bodies inside out: PML conquers the cytoplasm, Curr Opin Cell Biol, 23, 360, 10.1016/j.ceb.2011.03.011 Seo, 2006, Nuclear retention of the tumor suppressor cPML by the homeodomain protein TGIF restricts TGF-beta signaling, Mol Cell, 23, 547, 10.1016/j.molcel.2006.06.018 Faresse, 2008, Identification of PCTA, a TGIF antagonist that promotes PML function in TGF-beta signalling, EMBO J, 27, 1804, 10.1038/emboj.2008.109 Ettahar, 2013, Identification of PHRF1 as a tumor suppressor that promotes the TGF-beta cytostatic program through selective release of TGIF-driven PML inactivation, Cell Rep, 4, 530, 10.1016/j.celrep.2013.07.009 Pan, 2009, SnoN functions as a tumour suppressor by inducing premature senescence, EMBO J, 28, 3500, 10.1038/emboj.2009.250 Tang, 2013, Promyelocytic leukemia (PML) protein plays important roles in regulating cell adhesion, morphology, proliferation and migration, PLoS ONE, 8, e59477, 10.1371/journal.pone.0059477 Moreno, 2010, Specification of the NF-kappaB transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKK epsilon, Nucleic Acids Res, 38, 6029, 10.1093/nar/gkq439 Renner, 2010, SUMOylation-dependent localization of IKKepsilon in PML nuclear bodies is essential for protection against DNA-damage-triggered cell death, Mol Cell, 37, 503, 10.1016/j.molcel.2010.01.018 Jin, 2013, Emerging cellular functions of cytoplasmic PML, Front Oncol, 3, 147, 10.3389/fonc.2013.00147 Versteeg, 2013, The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors, Immunity, 38, 384, 10.1016/j.immuni.2012.11.013 Rajsbaum, 2014, TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity, J Mol Biol, 426, 1265, 10.1016/j.jmb.2013.12.005 Kawai, 2011, Regulation of innate immune signalling pathways by the tripartite motif (TRIM) family proteins, EMBO Mol Med, 3, 513, 10.1002/emmm.201100160 McNab, 2011, Tripartite-motif proteins and innate immune regulation, Curr Opin Immunol, 23, 46, 10.1016/j.coi.2010.10.021 Marin, 2012, Origin and diversification of TRIM ubiquitin ligases, PLoS ONE, 7, e50030, 10.1371/journal.pone.0050030 Meroni, 2005, TRIM/RBCC, a novel class of ‘single protein RING finger’ E3 ubiquitin ligases, BioEssays: News Rev Mol Cell Dev Biol, 27, 1147, 10.1002/bies.20304 Liang, 2011, Tripartite motif-containing protein 28 is a small ubiquitin-related modifier E3 ligase and negative regulator of IFN regulatory factor 7, J Immunol, 187, 4754, 10.4049/jimmunol.1101704 Zou, 2006, The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase, J Biol Chem, 281, 3989, 10.1074/jbc.M510787200 Van Damme, 2010, A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics, Int J Biol Sci, 6, 51, 10.7150/ijbs.6.51